SCHEMBL486107

SCHEMBL486107

NNc1ccc(-c2ccccc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.68
CYP3A4 P08684 2/20 0.68
CYP1A2 P05177 2/20 0.68
PTGS2 P35354 2/20 0.68
LMNA P02545 1/20 0.68
CYP2D6 P10635 1/20 0.68
CYP2C9 P11712 1/20 0.68
IDO1 P14902 1/20 0.68
CYP2C19 P33261 1/20 0.68
ALDH1A1 P00352 4/20 0.50
TAAR1 Q96RJ0 3/20 0.50
HSD17B10 Q99714 2/20 0.50
PTPN1 P18031 2/20 0.46
PTPN11 Q06124 1/20 0.46
FNTA P49354 1/20 0.44
FNTB P49356 1/20 0.44
MAPK1 P28482 2/20 0.43
MMP3 P08254 1/20 0.43
BCL2L1 Q07817 1/20 0.43
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5664263 0.97 CYP3A4 (0.65) TDP1CYP3A4CYP1A2PTGS2LMNA
Biphenyl SCHEMBL27571445 0.92 TDP1 (0.82) TDP1CYP3A4CYP1A2PTGS2LMNA
Biphenyl SCHEMBL27808430 0.89 TDP1 (0.78) TDP1CYP3A4CYP1A2PTGS2LMNA
SCHEMBL4094372 0.88 TDP1 (0.56) TDP1CYP3A4CYP1A2PTGS2LMNA
SCHEMBL10387580 0.87 CYP3A4 (0.67) TDP1CYP3A4CYP1A2PTGS2LMNA
Biphenyl SCHEMBL185563 0.85 LMNA (0.56) TDP1CYP3A4CYP1A2PTGS2LMNA
Hydrochloric Acid SCHEMBL31628644 0.85 TDP1 (0.53) TDP1CYP3A4CYP1A2PTGS2LMNA
Hydrochloric Acid SCHEMBL30096476 0.85 TDP1 (0.53) TDP1CYP3A4CYP1A2PTGS2LMNA
Hydrochloric Acid SCHEMBL30583826 0.82 TDP1 (0.50) TDP1CYP3A4CYP1A2PTGS2LMNA
Phenylhydrazine SCHEMBL7099 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112010798-A Method for synthesizing N-arylcarbazole compound by catalyzing reaction of carbazole and arylhydrazine with transition metal 新乡市润宇新材料科技有限公司 2020-12-01 CN claimed
US-7125428-B2 1,3-Dihydroxybenzene derivatives and colorants containing said compounds WELLA AG (DE) 2006-10-24 US claimed
US-7070626-B2 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds WELLA AG (DE) 2006-07-04 US claimed
US-6811573-B2 HAIR DYES; INTENSE, STABLE BLUE COLOR SHADES IN ADDITION TO NATURAL, PURPLE OR VIOLET ONES WELLA AKTIENGESELLSCHAFT (DE) 2004-11-02 US claimed
CN-119552120-A Pyrazole and imidazole compounds for inhibiting IL-17 and rory 里亚塔医药公司 2025-03-04 CN disclosed
CN-112654610-B Pyrazole and imidazole compounds for inhibiting IL-17 and rory 里亚塔医药公司 2024-12-24 CN disclosed
US-20240360084-A1 PYRAZOLE AND IMIDAZOLE COMPOUNDS FOR INHIBITION OF IL-17 AND RORGAMMA REATA PHARMACEUTICALS INC (US) 2024-10-31 US disclosed
CN-118530236-A Azaindoles method for synthesizing compound 大连理工大学 2024-08-23 CN disclosed
US-11993574-B2 Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma REATA PHARMACEUTICALS, INC (US) 2024-05-28 US disclosed
US-20210292281-A1 PYRAZOLE AND IMIDAZOLE COMPOUNDS FOR INHIBITION OF IL-17 AND RORGAMMA REATA PHARMACEUTICALS, INC. (US) 2021-09-23 US disclosed
EP-3807265-A1 PYRAZOLE AND IMIDAZOLE COMPOUNDS FOR INHIBITION OF IL-17 AND RORGAMMA Reata Pharmaceuticals, Inc. (US) 2021-04-21 EP disclosed
CN-112654610-A Pyrazole and imidazole compounds for inhibiting IL-17 and ROR gamma 里亚塔医药公司 2021-04-13 CN disclosed
US-4325962-A ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIDYRETICS BYK-GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1982-04-20 US disclosed
US-4268592-A PYRAZOLONE MAGENTA COUPLER CIBA-GEIGY AG (CH) 1981-05-19 US disclosed
US-4229463-A ANTICHOLESTEROL AGENTS FOR REDUCING CHOLESTEROL ESTER CONTENT OF ARTERIAL WALLS SANDOZ, INC. (US) 1980-10-21 US disclosed
US-4146721-A ANALGESICS, ANTIINFLAMMATORY AGENTS AND ANTIPYRETICS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1979-03-27 US disclosed
US-4093812-A MICROBIOCIDES, DISINFECTANTS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DT) 1978-06-06 US disclosed
US-3987234-A ACRYLIC ESTER POLYMERS HENKEL & CIE G.M.B.H. (DT) 1976-10-19 US disclosed
US-3979412-A Process for producing 3-anilino-5-pyrazolones FUJI PHOTO FILM CO., LTD. (JA) 1976-09-07 US disclosed
US-3933874-A Method for preparing of β-anilino-β-hydrazinoacrylates FUJI PHOTO FILM CO., LTD. (JA) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292281-A1 PYRAZOLE AND IMIDAZOLE COMPOUNDS FOR INHIBITION OF IL-17 AND RORGAMMA RORC, RORB, RORA TDP1 4258/4885CYP3A4 270/4885CYP1A2 169/4885
US-20240360084-A1 PYRAZOLE AND IMIDAZOLE COMPOUNDS FOR INHIBITION OF IL-17 AND RORGAMMA RORC, RORB, RORA TDP1 4258/4885CYP3A4 270/4885CYP1A2 169/4885
US-11993574-B2 Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma RORC, RORB, RORA TDP1 4258/4885CYP3A4 270/4885CYP1A2 169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.